Neuroimmune disorders in COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the aetiologic agent of the coronavirus disease 2019 (COVID-19), is now rapidly disseminating throughout the world with 147,443,848 cases reported so far. Around 30–80% of cases (depending on COVID-19 severity) are reported to have neurol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ariño, Helena, Heartshorne, Rosie, Michael, Benedict D., Nicholson, Timothy R., Vincent, Angela, Pollak, Thomas A., Vogrig, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120100/
https://www.ncbi.nlm.nih.gov/pubmed/35353232
http://dx.doi.org/10.1007/s00415-022-11050-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120100/
https://www.ncbi.nlm.nih.gov/pubmed/35353232
http://dx.doi.org/10.1007/s00415-022-11050-w

Ejemplares similares